BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 12492176)

  • 1. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs.
    Quan C; Talley NJ
    Am J Gastroenterol; 2002 Dec; 97(12):2950-61. PubMed ID: 12492176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.
    McColl KE
    Gastroenterol Clin North Am; 2009 Jun; 38(2):353-61. PubMed ID: 19446263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori-negative ulcer disease.
    McColl KE
    J Gastroenterol; 2000; 35 Suppl 12():47-50. PubMed ID: 10779218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori-negative peptic ulcers: frequency and implications for management.
    Freston JW
    J Gastroenterol; 2000; 35 Suppl 12():29-32. PubMed ID: 10779214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori-negative peptic ulcer. What is its aetiopathogenesis and treatment?
    Monés Xiol J
    Rev Esp Enferm Dig; 2002 Nov; 94(11):687-96. PubMed ID: 12690992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and peptic ulcer disease.
    Blum AL
    Scand J Gastroenterol Suppl; 1996; 214():24-7; discussion 42-3. PubMed ID: 8722401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peptic ulcer and Helicobacter pylori, diagnosis and therapy].
    Fixa B; Komárková O
    Cas Lek Cesk; 1999 Jun; 138(12):355-8. PubMed ID: 10566201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease.
    Chiorean MV; Locke GR; Zinsmeister AR; Schleck CD; Melton LJ
    Am J Gastroenterol; 2002 Dec; 97(12):3015-22. PubMed ID: 12492184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
    Cherian PT; Cherian S; Singh P
    Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori: criminal or innocent bystander?
    Arakawa T; Higuchi K; Fujiwara Y; Tominaga K; Watanabe T; Shiba M; Uchida T; Kuroki T
    J Gastroenterol; 2000; 35 Suppl 12():42-6. PubMed ID: 10779217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and non-malignant diseases.
    Matysiak-Budnik T; Laszewicz W; Lamarque D; Chaussade S
    Helicobacter; 2006 Oct; 11 Suppl 1():27-31. PubMed ID: 16925608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori in ulcerogenesis.
    Lin SK; Lambert JR
    Scand J Gastroenterol Suppl; 1995; 210():64-9. PubMed ID: 8578211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.